Imaging of NAFLD

Takeshi Yokoo, An Tang, Claude B. Sirlin

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

The role of imaging in the assessment of non-alcoholic fatty liver disease (NAFLD) is expanding; it now includes the diagnosis, severity grading, and longitudinal monitoring of hepatic steatosis. Imaging also permits assessment of the advanced features of NAFLD and its complications, such as fibrosis, cirrhosis, portal hypertension, and hepatocellular carcinoma. In addition, imaging is frequently utilized to measure primary or secondary endpoints in NAFLD-related research studies. Ultrasound (US), computed tomography (CT), and magnetic resonance (MR) techniques are useful noninvasive tools for these purposes. Conventional grayscale US, unenhanced CT, and in- and out-of-phase MR methods have established roles in the detection of steatosis. Refinements of these methods allow quantification of the severity of steatosis. New imaging techniques that quantify elastic, perfusion, and diffusion properties of the liver show promise for assessment of fibrosis and pre-clinical cirrhosis, and they are increasing in clinical availability. Imaging techniques for the differentiation between steatohepatitis and isolated steatosis are in development or in early phases of evaluation, but developments in this exciting area have not yet been validated.

Original languageEnglish (US)
Title of host publicationNon-Alcoholic Fatty Liver Disease: A Practical Guide
PublisherWiley-Blackwell
Pages93-111
Number of pages19
ISBN (Print)9780470673171
DOIs
StatePublished - Mar 8 2013

Fingerprint

Fibrosis
Magnetic Resonance Spectroscopy
Tomography
Liver
Portal Hypertension
Fatty Liver
Hepatocellular Carcinoma
Perfusion
Non-alcoholic Fatty Liver Disease
Research

Keywords

  • Biomarkers
  • Computed tomography
  • Diagnosis
  • Fibrosis
  • Imaging
  • Magnetic resonance
  • Noninvasive
  • Quantification
  • Steatohepatitis
  • Steatosis
  • Ultrasound

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Yokoo, T., Tang, A., & Sirlin, C. B. (2013). Imaging of NAFLD. In Non-Alcoholic Fatty Liver Disease: A Practical Guide (pp. 93-111). Wiley-Blackwell. https://doi.org/10.1002/9781118556153.ch9

Imaging of NAFLD. / Yokoo, Takeshi; Tang, An; Sirlin, Claude B.

Non-Alcoholic Fatty Liver Disease: A Practical Guide. Wiley-Blackwell, 2013. p. 93-111.

Research output: Chapter in Book/Report/Conference proceedingChapter

Yokoo, T, Tang, A & Sirlin, CB 2013, Imaging of NAFLD. in Non-Alcoholic Fatty Liver Disease: A Practical Guide. Wiley-Blackwell, pp. 93-111. https://doi.org/10.1002/9781118556153.ch9
Yokoo T, Tang A, Sirlin CB. Imaging of NAFLD. In Non-Alcoholic Fatty Liver Disease: A Practical Guide. Wiley-Blackwell. 2013. p. 93-111 https://doi.org/10.1002/9781118556153.ch9
Yokoo, Takeshi ; Tang, An ; Sirlin, Claude B. / Imaging of NAFLD. Non-Alcoholic Fatty Liver Disease: A Practical Guide. Wiley-Blackwell, 2013. pp. 93-111
@inbook{7919366a53234c64a3a90022366b5ff3,
title = "Imaging of NAFLD",
abstract = "The role of imaging in the assessment of non-alcoholic fatty liver disease (NAFLD) is expanding; it now includes the diagnosis, severity grading, and longitudinal monitoring of hepatic steatosis. Imaging also permits assessment of the advanced features of NAFLD and its complications, such as fibrosis, cirrhosis, portal hypertension, and hepatocellular carcinoma. In addition, imaging is frequently utilized to measure primary or secondary endpoints in NAFLD-related research studies. Ultrasound (US), computed tomography (CT), and magnetic resonance (MR) techniques are useful noninvasive tools for these purposes. Conventional grayscale US, unenhanced CT, and in- and out-of-phase MR methods have established roles in the detection of steatosis. Refinements of these methods allow quantification of the severity of steatosis. New imaging techniques that quantify elastic, perfusion, and diffusion properties of the liver show promise for assessment of fibrosis and pre-clinical cirrhosis, and they are increasing in clinical availability. Imaging techniques for the differentiation between steatohepatitis and isolated steatosis are in development or in early phases of evaluation, but developments in this exciting area have not yet been validated.",
keywords = "Biomarkers, Computed tomography, Diagnosis, Fibrosis, Imaging, Magnetic resonance, Noninvasive, Quantification, Steatohepatitis, Steatosis, Ultrasound",
author = "Takeshi Yokoo and An Tang and Sirlin, {Claude B.}",
year = "2013",
month = "3",
day = "8",
doi = "10.1002/9781118556153.ch9",
language = "English (US)",
isbn = "9780470673171",
pages = "93--111",
booktitle = "Non-Alcoholic Fatty Liver Disease: A Practical Guide",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Imaging of NAFLD

AU - Yokoo, Takeshi

AU - Tang, An

AU - Sirlin, Claude B.

PY - 2013/3/8

Y1 - 2013/3/8

N2 - The role of imaging in the assessment of non-alcoholic fatty liver disease (NAFLD) is expanding; it now includes the diagnosis, severity grading, and longitudinal monitoring of hepatic steatosis. Imaging also permits assessment of the advanced features of NAFLD and its complications, such as fibrosis, cirrhosis, portal hypertension, and hepatocellular carcinoma. In addition, imaging is frequently utilized to measure primary or secondary endpoints in NAFLD-related research studies. Ultrasound (US), computed tomography (CT), and magnetic resonance (MR) techniques are useful noninvasive tools for these purposes. Conventional grayscale US, unenhanced CT, and in- and out-of-phase MR methods have established roles in the detection of steatosis. Refinements of these methods allow quantification of the severity of steatosis. New imaging techniques that quantify elastic, perfusion, and diffusion properties of the liver show promise for assessment of fibrosis and pre-clinical cirrhosis, and they are increasing in clinical availability. Imaging techniques for the differentiation between steatohepatitis and isolated steatosis are in development or in early phases of evaluation, but developments in this exciting area have not yet been validated.

AB - The role of imaging in the assessment of non-alcoholic fatty liver disease (NAFLD) is expanding; it now includes the diagnosis, severity grading, and longitudinal monitoring of hepatic steatosis. Imaging also permits assessment of the advanced features of NAFLD and its complications, such as fibrosis, cirrhosis, portal hypertension, and hepatocellular carcinoma. In addition, imaging is frequently utilized to measure primary or secondary endpoints in NAFLD-related research studies. Ultrasound (US), computed tomography (CT), and magnetic resonance (MR) techniques are useful noninvasive tools for these purposes. Conventional grayscale US, unenhanced CT, and in- and out-of-phase MR methods have established roles in the detection of steatosis. Refinements of these methods allow quantification of the severity of steatosis. New imaging techniques that quantify elastic, perfusion, and diffusion properties of the liver show promise for assessment of fibrosis and pre-clinical cirrhosis, and they are increasing in clinical availability. Imaging techniques for the differentiation between steatohepatitis and isolated steatosis are in development or in early phases of evaluation, but developments in this exciting area have not yet been validated.

KW - Biomarkers

KW - Computed tomography

KW - Diagnosis

KW - Fibrosis

KW - Imaging

KW - Magnetic resonance

KW - Noninvasive

KW - Quantification

KW - Steatohepatitis

KW - Steatosis

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=84886144129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886144129&partnerID=8YFLogxK

U2 - 10.1002/9781118556153.ch9

DO - 10.1002/9781118556153.ch9

M3 - Chapter

AN - SCOPUS:84886144129

SN - 9780470673171

SP - 93

EP - 111

BT - Non-Alcoholic Fatty Liver Disease: A Practical Guide

PB - Wiley-Blackwell

ER -